Warfare Terrorism Carstairs - ACMT · 2014-09-29 · Biological Warfare" Ricin! • Ricinus...
Transcript of Warfare Terrorism Carstairs - ACMT · 2014-09-29 · Biological Warfare" Ricin! • Ricinus...
8/11/14
1
Warfare/Terrorism/HAZMAT CDR Shaun D. Carstairs
Department of Emergency Medicine Naval Medical Center San Diego
San Diego, CA
Warfare/Terrorism/HAZMAT
• Chemical
• Nuclear
• Biological
• Hazardous Materials
Disclosure
• The views expressed herein are solely those of the speaker and in no way reflect the official policy, position, or doctrine of the U.S. Navy, Department of Defense, or the U.S. Government.
• The contents of this presentation are not endorsed in any way by the U.S. Navy, Department of Defense, or the U.S. Government.
8/11/14
2
Thank You…
• …to COL J. Dave Barry for his work on previous versions of these slides
The Core Content of Medical Toxicology
3% of the content.
Chemical Agents
• Nerve agents
• Blister agents
• Incapacitating agents
• Riot control agents
• Pulmonary agents
• Blood agents (cyanogens)
8/11/14
3
Chemical Agents���Nerve Agents
• History • 1930’s: Nazis synthesize “G” agents during WWII
• Never used in battle • Tested in concentration camps
• 1940’s: Soviet Union begins production after capturing German munitions
• 1950’s: U.S. begins production • 1990’s: Aum Shinrikyo cult (Matsumoto ‘94, Tokyo ’95), Iraq
against Kurdish minority
Chemical Agents���Nerve Agents
C
T
L
S
ne
ne
Autonomic Nervous System parasympathetic sympathetic
N
N
N
N
N
M
M
M
8/11/14
4
C
T
L
S
N
N
N
N
M
M
N
ne
ne
Sympathetic Parasympathetic (cholinergic)
M mio
sec
sec
hr
sec
mot
mict
sec
agit
Sz
Fasic
paraly
hr vasoconstr
rr
Property Tabun (GA) Sarin (GB) Soman (GD) VX Volatility (mg/m3) 610 22000 3900 10.5
Persistency on soil 1-1.5 d 2-24 h Relatively persistent 2-6 days
LCt50 in humans (mg min per m3) 400 100 50 10
LD50 in humans (mg per 70 kg human) 1000 1700 350 6-10
Aging half-life >14 h 3 h 2-6 min 48 h
http://www.atsdr.cdc.gov/csem/csem.asp?csem=11&po=23
Chemical Agents���Nerve Agents
Chemical Agents���Nerve Agents
• Personal Protection
• Respiratory
• Skin
• Decontamination
• Soap/water
• Alkaline solutions (diluted sodium hypochlorite)
8/11/14
5
Chemical Agents���Nerve Agents
• Treatment
• Atropine – combat excess
muscarinic ACh
• Goal – dry respiratory secretions
• Diazepam – combat excess nicotinic Ach
• Oximes (e.g., 2-PAM) – combat “aging”
Chemical Agents���Nerve Agents
• Pretreatment
• Pyridostigmine
• Carbamate (reversible) – protects small % of AChE from irreversible OP aging
8/11/14
6
Chemical Agents���Blister Agents
• Mustards
• Sulfur mustard (HD)
• Nitrogen mustard (HN)
• Lewisite (L)
• Phosgene oxime (CX)
Chemical Agents���Blister Agents
• History
• 1917 – WWI, Ypres
• 1930’s – Italians in Ethiopia
• 1940’s – WWII
• Japanese vs. Chinese
• German/Japanese conc. camps
• 1960’s Egypt vs. Yemen (alleged)
• 1980’s Iraq vs. Iran
• 2014 Syria
High casualty rate, low mortality (>20:1)
Chemical Agents���Blister Agents
Agent Form Color Odor Pain Tissue Damage Blister Persistence
Sulfur mustard (HD)
Liquid Pale yellow
to dark brown
Garlic, onion, or mustard
Hours later
Immediate, but effects delayed till hours later
Fluid-filled
2 weeks-3 years
Lewisite (L) Liquid
Colorless to amber or black
Geranium-like Immediate Seconds to
minutes Fluid-filled Days
Phosgene oxime (CX)
Solid or liquid
Colorless as solid,
brown as liquid
Irritating Immediate Seconds Solid wheal 2 hours
8/11/14
7
Chemical Agents���Mustard
• Mechanism • Alkylating agent
• “Cyclization” à reactive sulfonium ion
• Alkylates sulfhydryl (-SH) and amino (-NH2) groups
• Depletes glutathione • Increased oxidative stress
Chemical Agents���Mustard
• Clinical effects
• Vapor or liquid exposure
• Cellular damage within 1-2 min
• Clinical effects 2-48 hrs (usually 4-8 hrs)
Chemical Agents���Mustard
• Skin: erythema à vesicles à blisters/bullae
• Eyes: mild à severe conjunctivitis
• Blindness possible
• Airways: bronchospasm, pulmonary edema, obstruction/hemorrhage in severe cases
8/11/14
8
Chemical Agents���Mustard
• GI: Nausea/vomiting, GI bleed
• Systemic:
• BM suppression & immunosuppression (high doses)
• IARC Group I – respiratory cancer
Chemical Agents���Mustard
• Diagnosis • M8, M9 paper, etc.
• Thiodiglycol (urine, blood)
• Treatment • Decontamination
• Supportive/symptomatic care
• No antidote
Chemical Agents���Mustard
• Decontamination
• Remove large globs or liquid
• Soap/water, diluted hypochlorite
• Military self-decontamination kits
8/11/14
9
Chemical Agents���Lewisite
• History • Less persistent alternative to
mustard agents • No confirmed battlefield use
• Mechanism unclear • Similar to other arsenicals? • Inhibition of pyruvate
dehydrogenase/other enzymes
Chemical Agents���Lewisite
• Clinical effects • Immediate (unlike mustard) • Skin: erythema, vesicles,
blisters • Eyes: conjunctivitis • Airways: MM irritation,
pulmonary edema
• Treatment • Same as mustard • BAL (British anti-Lewisite)
(dimercaprol) • Topical/systemic
Chemical Agents���Phosgene Oxime
• Background • No battlefield use • Penetrates garments more
quickly than other agents • Rapid onset, severe and
prolonged effects
• Mechanism • Unclear • Not a true vesicant • Irritant or “nettle” agent
8/11/14
10
Chemical Agents���Phosgene Oxime
• Clinical effects • Immediate, severe tissue
damage • Skin: erythema, wheals,
urticaria • Eyes: conjunctivitis • Airways: pulmonary edema
• Treatment • Supportive • No antidote
Chemical Agents���Incapacitating Agents
• U.S. experimented with multiple agents • Antimuscarinics felt to be most promising
• BZ (3-quinuclidinyl benzilate) • Physostigmine is potential antidote
• Opioids • Kolokol-1 (fentanyl analogue)
• 2002 Chechen Moscow theater siege
Chemical Agents���Riot Control Agents
• CN (chloracetophenone) – Mace ®
• CS (O-chlorobenzilidene malenonitrile)
• Capsaicin (“pepper spray”)
• Chloropicrin (trichloronitromethane)
• Adamsite (DM) – vomiting agent
8/11/14
11
Chemical Agents���Riot Control Agents
• OC – Capsaicin (“pepper spray”)
• Better safety margin/more potent
• Release of Substance P à “neurogenic inflammation”
Chemical Agents���Pulmonary Agents
• Phosgene (CG)
• Diphosgene (DP)
• Chlorine (Cl)
• Nitrogen oxides (NOx)
• Perfluoroisobutylene (PFIB)
Chemical Agents���Pulmonary Agents
Agent Color Physical State Odor Water Solubility
Timing of Effects
Chlorine (Cl) Yellow-green
Gas; with pressure and cooling can be
liquid Strong bleach Intermediate
Immediate irritation,
pulmonary edema 2-24
hrs later
Phosgene (CG)
Colorless or white to pale-yellow liquid
Gas; with pressure and cooling can be
liquid
Freshly mown hay, green corn Poor
Delayed up to 48 hrs
(usually 2-6 hrs)
Diphosgene (DP) Colorless Gas Freshly mown
hay, green corn Poor
Delayed up to 48 hrs
(usually 2-6 hrs)
8/11/14
12
Chemical Agents���Perfluoroisobutylene (PFIB)
• Similar toxicity to phosgene
• 10x as potent
• Delayed pulmonary toxicity
• Formed from pyrolysis of PTFE
Nuclear/Radiological
• Atomic radiation primer
• Measurement
• Acute radiation syndrome/dosimetry
• Treatment of radiation injuries
• Scenarios
• Specific radionuclides
Nuclear/Radiological���Atomic Radiation Primer
• Nonionizing radiation • Doesn’t have enough energy
to disrupt atoms or molecules • Ionizing radiation
• Radiation with enough energy to disrupt an atom or molecule that it hits
8/11/14
13
Nuclear/Radiological���Atomic Radiation Primer
• Ionizing radiation effects • DNA effects
• Repairable damage
• Mutations
• Cell death
Nuclear/Radiological���Atomic Radiation Primer
• Ionizing radiation effects • Free radical formation
• Hydroxyl free radicals
Nuclear/Radiological���Atomic Radiation Primer
• Ionizing radiation effects • Dose absorbed depends
upon:
• Time
• Distance (1/r2)
• Shielding
8/11/14
14
Nuclear/Radiological���Atomic Radiation Primer
Nuclear/Radiological���Atomic Radiation Primer
Nuclear/Radiological���Atomic Radiation Primer
8/11/14
15
Nuclear/Radiological���Measurement
Gamma Spectroscopy
Nuclear/Radiological���Acute Radiation Syndrome
Nuclear/Radiological���Acute Radiation Syndrome
• Four stages • Prodromal: nausea/vomiting, diarrhea, anorexia; occurs minutes to
days following exposure • Latent: relatively asymptomatic for hours to days • Manifest (clinical) illness:
• Hematologic syndrome (>0.7 Gy, >70 rad) • Gastrointestinal syndrome (>10 Gy, >1000 rad) • CNS syndrome (>50 Gy, >5000 rad)
• Recovery or death
8/11/14
16
Nuclear/Radiological���Dosimetry
• Lymphocyte reduction
• Drop in lymphocytes q6 hours
• Dose proportional to rate of decline of lymphocytes
Nuclear/Radiological���Dosimetry
• Chromosomal cytogenetics
• # of aberrations proportional to dose
Nuclear/Radiological���Treatment
• Treat conventional (life-threatening) injuries first! • Decontaminate (if necessary)
• External decon (remove clothes, decontaminate wounds first) • Internal decon
• Dosimetry screen • CBC w/diff q6 hrs • Absolute lymphocyte count (ALC)
8/11/14
17
Nuclear/Radiological���Treatment
• Internal decontamination
• Antacid: decrease absorption, precipitate to insoluble salt
• Saturate critical organ with stable isotope; e.g. KI for 131I exposure
• Chelation: DTPA (239Pu), Prussian blue (137Cs), BAL, etc.
• Catharsis (decrease residence time)
Nuclear/Radiological���Treatment
• Supportive care
• Antimicrobials, antiemetics, antidiarrheals, anxiolytics
• IV fluids, electrolytes, analgesics, burn therapy, psychosocial care
• Surgical intervention in first 36 hrs
• Stimulation of hematopoietic system (cytokines, CSF’s)
Nuclear/Radiological���Sources/Scenarios
• Simple radiological device
• Radiological dispersal device
• Reactor accident – “meltdown”
• Improvised nuclear device
• Nuclear weapon
8/11/14
18
Nuclear/Radiological���Specific Radionuclides
• Iodine (131I) • t1/2 = 8.03 days, emits beta/gamma radiation
• Low levels in hospital nuclear medicine departments
• Nuclear reactor accidental releases/nuclear weapons
• Accumulates in thyroid tissue
• If incorporated à thyroid damage
• Prophylactic treatment with potassium iodide (KI)
Nuclear/Radiological���Specific Radionuclides
• Depleted uranium (238U) • t1/2 = 4.5 billion years, emits alpha/beta/gamma radiation
• 0.7x as radioactive as natural uranium
Nuclear/Radiological���Specific Radionuclides
• Depleted uranium (238U) • Low risk radiation hazard
• Internal contamination (inhalation) is controversial
• Primarily a chemical toxicity (renal toxicity)
8/11/14
19
Nuclear/Radiological���Specific Radionuclides
• Thorotrast (232ThO2) • Angiographic contrast agent
used in 1930’s • Long t1/2 (400 yrs?); internal
alpha radiation • Inc. incidence of malignancies
• Liver CA, leukemia, angiosarcoma
• IARC 1
Biological Warfare
• Toxins
• Bacteria
• Viruses
Biological Warfare���Toxins
• Botulinum toxin
• Ricin
• Staphylococcal enterotoxin B (SEB)
• T-2 mycotoxins
8/11/14
20
Biological Warfare���Botulinum Toxin
• Produced by Clostridium botulinum • 7 antigenic types: A-G
• Military relevance • Most potent toxin known, easily produced • Weaponized by several countries/entities
• Soviet Union, Iran, Iraq, N. Korea, Syria • U.S. (1960’s) – known as Agent X • Terrorists – Aum Shinrikyō (1990’s)
Arnon SS et al. JAMA 2001; 285:1059-1070
Biological Warfare���Botulinum Toxin
• Foodborne: toxin ingestion after production by bacteria in (canned) food
• Infant: intestinal colonization • Wound: colonization • Inhalational: weaponized agents • All have similar clinical picture
• Progressive descending flaccid paralysis • Always starts with cranial nerve/bulbar involvement
8/11/14
21
Biological Warfare���Botulinum Toxin
• Diagnosis • Mouse neutralization assay • ELISA • Wound or stool culture
Biological Warfare���Botulinum Toxin
• Treatment • Supportive care • Antitoxin
• Bivalent (A, B) – BabyBIG ® – human-derived • Trivalent (A, B, E) –equine-derived whole Ab • Heptavalent (A-G) – equine-derived Fab2
• Vaccine (investigational)
Biological Warfare���Ricin
• Ricinus communis (castor bean) • Attractive as a biological weapon since it is widely available,
cheap, and has heat-stable toxin • History
• Compound W (WWII) • Georgi Markov (1978)
8/11/14
22
Biological Warfare���Ricin
• Mechanism: inhibits protein synthesis • B chain – binds to cell surface, undergoes endocytosis to enter
cell • A chain – binds to and inhibits 60S ribosome, inhibiting protein
synthesis
Biological Warfare���Ricin
• Symptoms • Vary based upon route of exposure • Oral – N/V/D, vascular collapse, shock • Intramuscular – local pain, regional painful swollen lymph nodes,
multi-organ failure • Inhalational – pulmonary edema, pneumonia, mediastinal
lymphadenitis, multi-organ failure
Biological Warfare���Ricin
• Diagnosis • ELISA assay of nasal swab, blood, or other body fluids
• Treatment • Supportive care
• AC may bind orally ingested toxin • No antidote
• Prophylaxis • Vaccine being investigated
8/11/14
23
Biological Warfare���Staphylococcal Enterotoxin B
• Military relevance • Potent compared to chemical agents • Incapacitating (usually not lethal) • Studied by U.S. in 1960’s as biological incapacitant
Biological Warfare���Staphylococcal Enterotoxin B
• “Superantigens” à profound activation of immune system • Bind monocytes (MHC Class II molecules) à stimulation of
helper T-cells à massive release of cytokines (interferon gamma, IL-6, TNF-α) à intense inflammatory response
Biological Warfare���Staphylococcal Enterotoxin B
• Gastrointestinal syndrome • Identical to staphylococcal food poisoning
• Pulmonary syndrome • Inhalation of weaponized toxin
8/11/14
24
Biological Warfare���T-2 Mycotoxin
• Byproduct of Fusarium spp. • Alimentary toxic aleukia (ALA) • “Yellow rain” – Laos/Kampuchea • Purported cause of Gulf War Syndrome
Biological Warfare���Bacteria
• Anthrax
• Plague
• Tularemia
• Brucellosis
• Q Fever
Biological Warfare���Anthrax
• Bacillus anthracis • Gram-positive, encapsulated, spore-forming bacillus
• Virulence factors • Antiphagocytic capsule • Lethal toxin • Edema toxin
8/11/14
25
Biological Warfare���Anthrax
• Virulence factors • Antiphagocytic capsule – no virulence without this capsule • Lethal toxin
• Zinc metalloproteinase – stimulates macrophages to release TNF and IL-6
• Edema toxin • Calmodulin-dependent adenylate cyclase – increased cAMP
leads to massive edema and impaired neutrophil function
Biological Warfare���Anthrax
• Pathophysiology • Spores exist worldwide in soil • Spores enter body, are ingested by macrophages and germinate
• Incubation period 1-6 days • Bacteria multiply in local lymph nodes leading to:
• Edema • Hemorrhage • Tissue necrosis
Biological Warfare���Anthrax
• Cutaneous anthrax • 95% of cases, 2000 annually
worldwide • Vesicle à painless necrotic
ulcer à lymphadenitis à black eschar à scar
• Septicemia rare
8/11/14
26
Biological Warfare���Anthrax
• Inhalational anthrax • Woolsorter’s disease • Aerosolized release as a
biological weapon • Fever, malaise, myalgia, fatigue • Chest pain, respiratory
distress • Widened mediastinum • Mortality approaches 100%
Biological Warfare���Anthrax
• Gastrointestinal anthrax • Rare but high mortality (25-60%) • Ingestion of poorly cooked, contaminated meat • N/V/D, abdominal pain à ascites, hematemesis à toxemia, shock,
death
Biological Warfare���Anthrax
• Treatment • Ciprofloxacin • Doxycycline • Penicillin • Raxibacumab – monoclonal Ab against lethal toxin of B. anthracis
• Inhalational anthrax
8/11/14
27
Biological Warfare���Anthrax
• Immunization • Cell-free vaccine
• Attenuated, unencapsulated strain • Main ingredient is “protective antigen” • FDA approved for “at-risk populations” • Series of 6 shots with annual booster
Biological Warfare���Anthrax
• Prophylaxis
Bartlett JG et al. Clin Inf Dis 2002; 35:851-8
Biological Warfare���Plague
• Siege of Caffa, 1346 • Corpses of plague victims catapulted into city
Bartlett JG et al. Clin Inf Dis 2002; 35:851-8
8/11/14
28
Biological Warfare���Plague
• World War II • Japanese Army Unit 731 dropped plague-infected fleas over
China • Soviet Union, 1970s-1980s
• Reported to have genetically engineered, dry, antibiotic-resistant form of plague
Biological Warfare���Plague
• Yersinia pestis • Gram-negative bacillus • Transmission
• Flea vectors from rodent hosts • Respiratory droplets from infected animals/humans
• Very effective BW agent • Can be aerosolized • No effective vaccine
Biological Warfare���Plague
• Bubonic plague • Incubation period 2-10 days • 85-90% of cases historically • Fever, malaise, enlarged lymph
nodes • Secondary septicemia occurs
in ~25% of patients • Distal gangrene – “Black
Death”
8/11/14
29
Biological Warfare���Plague
• Pneumonic plague • Infection of lungs with Y.
pestis
• Incubation period 2-3 days • 5-15% of cases historically • Fever, malaise, cough,
hemoptysis • Bilateral alveolar infiltrates • Almost universally fatal
Biological Warfare���Plague
• Treatment • Streptomycin or gentamicin • Alternatives: Ciprofloxacin, doxycycline, chloramphenicol • Isolation to prevent secondary cases
• Postexposure prophylaxis • Ciprofloxacin • Doxycycline • Chloramphenicol
Biological Warfare���Plague
• Vaccination • Killed whole-cell vaccine • Effective against bubonic plague • Does not reliably protect against pneumonic plague
8/11/14
30
Biological Warfare���Tularemia
• Francisella tularensis • Gram-negative coccus
• Different presentations • Ulceroglandular (most common) – skin ulcer/lymphadenopathy • Glandular • Oculoglandular • Oropharyngeal • Pneumonic (most serious) – likely with weaponization – cough,
chest pain, SOB
Biological Warfare���Tularemia
• Ideal bioweapon • Easily aerosolized • Highly infective (10-50 bacteria needed) • Highly incapacitating
• Treatment • Doxycycline • Gentamicin
Biological Warfare���Brucellosis
• Brucella spp. • Gram-negative cocci • Typically contracted from unpasteurized milk or contaminated
meat • Nonspecific symptoms (fever, chills, malaise) • High morbidity, low mortality • Treatment
• Doxycycline + rifampin
8/11/14
31
Biological Warfare���Q Fever
• Coxiella burnetii • Rickettsia-like organism • Can cause disease from inhalation of single organism! • Nonspecific symptoms
• Fever, headache, fatigue, myalgias • Pulmonary infiltrates in 50% of patients • Treatment
• Doxycycline or tetracycline
Biological Warfare���Viruses
• Smallpox
• Equine encephalitis
• Viral hemorrhagic fevers (VHF)
Biological Warfare���Smallpox
• Variola virus (poxvirus) • Large enveloped DNA virus • Certified by WHO as eradicated in 1977
• Military relevance • Infectious as aerosol • Increasingly naïve (unimmunized) population • Easy large-scale production, stable virus
8/11/14
32
Biological Warfare���Smallpox
• Incubation – not contagious (7-17 d) • Prodrome – viral syndrome (2-4 d) • Rash – highly contagious
• Vesicular à pustular à umbilicated à scab • Scabs form 10-14 d after onset of rash
• Recovery – immunity • No longer contagious once all scabs separate • 14-28 d after rash onset
Biological Warfare���Smallpox
• Rash • Centrifugal • Synchronous (all in same
stage) • Highly contagious by
aerosol • 30% mortality in
unvaccinated population
Biological Warfare���Smallpox
8/11/14
33
Biological Warfare���Smallpox
• Laboratory diagnosis • Virus isolation from pharyngeal swab or scab material (PCR,
ELISA) • Treatment
• Supportive care • Isolation (and vaccination) of patient and all contacts for 17 d • Vaccination (within 4 d) • VIG (within 1 week) • Cidofovir
Biological Warfare���Smallpox
• Vaccination • Vaccinia – poxvirus related to
cowpox • Scarification with bifurcated
needle • Contraindicated in:
immunosuppressed, HIV, eczema, pregnancy, children <18 months
Biological Warfare���Equine Encephalitis
• Venezuelan Equine Encephalitis • Weaponized during Cold War • Symptoms
• Fever, headache, myalgias • Low mortality
8/11/14
34
Biological Warfare���Viral Hemorrhagic Fevers
• Filoviridae • Ebola/Marburg viruses
• Arenaviridae • Lassa fever
• Bunyaviridae • Rift Valley fever
• Flaviviridae • Yellow fever, Omsk hemorrhagic fever, Kyasanur forest disease
Biological Warfare���Viral Hemorrhagic Fevers
• Symptoms • Fever • Headache • Bleeding/DIC (Ebola, Marburg, Lassa) • Rash
• Mortality up to 90% with Ebola/Marburg (others 0-20%) • Treatment: supportive
Hazardous Materials
• Treaties
• Incident Command System, Site Safety
• National Pharmaceutical Stockpile
• Regulatory/Legal Acts
8/11/14
35
Hazardous Materials
http://www.globalsecurity.org/security/library/policy/army/fm/3-11-21/appc.htm
Hazardous Materials
Warfare/Terrorism/HAZMAT
• Chemical
• Nuclear
• Biological
• Hazardous Materials